|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/605 | (2006.01) |
| A61K 38/26 | (2006.01) |
| (11) | Number of the document | 2490709 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10825678.5 |
| Date of filing the European patent application | 2010-10-21 | |
| (97) | Date of publication of the European application | 2012-08-29 |
| (45) | Date of publication and mention of the grant of the patent | 2014-11-26 |
| (46) | Date of publication of the claims translation | 2015-02-25 |
| (86) | Number | PCT/US2010/053570 |
| Date | 2010-10-21 |
| (87) | Number | WO 2011/050174 |
| Date | 2011-04-28 |
| (30) | Number | Date | Country code |
| 254490 P | 2009-10-23 | US | |
| 09173900 | 2009-10-23 | EP |
| (72) |
ALAGARSAMY, Sudarkodi, US
JIANG, Guangcheng, US
RIVIERE, Pierre, NL
SCHTEINGART, Claudio, Daniel, US
SUEIRAS-DIAZ, Javier, US
WISNIEWSKI, Kazimierz, US
|
| (73) |
Ferring BV,
Polaris Avenue 144, 2132 JX Hoofddorp,
NL
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Peptidiniai GLP-2 agonistai |
| PEPTIDIC GLP-2 AGONISTS |
| Payment date | Validity (years) | Amount | |
| 2025-10-07 | 16 | 347.00 EUR |
| 2026-10-21 |